Medical Equipment

Global Epigenetics Market 2025–2029: Competitive Insights and Opportunities

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Global Market Value Of The Epigenetics Industry In 2025?#_x000D_

The overall valuation of the epigenetics market has witnessed substantial expansion lately, projected to ascend from its 2024 figure of $10.65 billion to reach $12.74 billion by 2025, reflecting a compound annual growth rate (CAGR) of 19.6%; this vigorous expansion seen during the past period stemmed from various factors including augmented financial backing for research endeavors, a growing prevalence of long-term illnesses, the advancement of tailored medical treatments, intensifying efforts in cancer studies, and the demographic shift towards an older populace._x000D_

_x000D_

The overall valuation of the epigenetics sector is projected to undergo substantial escalation over the forthcoming years, culminating in a market size of $28.68 billion by 2029, driven by a compound annual growth rate (CAGR) of 22.5%. This anticipated expansion throughout the projection timeframe is fundamentally linked to several key factors, such as advancements in epigenetic therapeutic agent creation, the application of epigenetics within ecological wellbeing studies, its integration into targeted crop management, favorable governmental policies, and increased cognizance and support activities among the public. During this forecast interval, the primary industry trajectories involve developments in epitranscriptomics, the study of epigenomics at the resolution of a single cell, mechanisms for epigenetic modification, identifying epigenetic indicators, investigations into senescence and lifespan extension, and the reciprocal relationship between the microbiome and the epigenome._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp_x000D_

_x000D_

#What Are The Key Drivers Of Growth In The Epigenetics Market?#_x000D_

The notable increase in instances of cancer alongside other illnesses is a major catalyst for the expansion observed within the epigenetics sector; this surge in disease frequency directly fuels the need for epigenetics solutions. To illustrate this point, data released in May 2024 by the National Cancer Institute, a governmental body in the U.S., showed that roughly 20 million new cancer diagnoses were made globally in 2022, contributing to an estimated 9.7 million fatalities attributed to the ailment, with forecasts suggesting that by 2040, the yearly count of new cancer cases will climb to 29.9 million, alongside 15.3 million cancer-related deaths. Moreover, statistics from the Centers for Disease Control and Prevention (CDC) reveal an annual toll of approximately 659,000 cardiovascular disease deaths within the United States. Consequently, the escalating rates of cancer and similar conditions necessitate advanced diagnostic capabilities to identify underlying genetic alterations, which consequently boosts the adoption and requirement for epigenetic technologies, thus positioning the rising incidence of these ailments as a key driver for the epigenetics market in the foreseeable future._x000D_

_x000D_

#What Are The Different Segment Classifications Within The Epigenetics Market?#_x000D_

The epigeneticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Reagents, Enzymes, Instruments, Kits _x000D_

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures _x000D_

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications _x000D_

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes_x000D_

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes_x000D_

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers_x000D_

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits_x000D_

_x000D_

#Which Competitive Trends Are Defining The Epigenetics Market Structure?#_x000D_

Leading enterprises within the epigenetics sector are concentrating efforts toward creating sophisticated technological instruments, exemplified by advancements in DNA sequencing methodologies, with the ultimate goal of elevating the effectiveness of personalized healthcare and deepening comprehension of ailments along with their therapeutic results. Determining the precise sequence of nucleobases within a deoxyribonucleic acid structure constitutes DNA sequencing—a process vital for in-depth genetic scrutiny. This resulting data proves indispensable for pinpointing genetic alterations linked to various conditions and propelling the field of precision medicine forward. To illustrate, during March of 2023, the American biotech firm Illumina Inc. introduced its Complete Long Read Technology, a dual-capability system allowing both extended and brief sequencing reads from one piece of equipment, thereby markedly boosting adaptability in genomic studies, while simultaneously demanding less initial DNA material and featuring a simplified procedure that eases the burden of preparing samples, even those that present difficulties, ultimately delivering superior accuracy in identifying variations which furnishes dependable information necessary for exhaustive genomic evaluation._x000D_

_x000D_

#Which Major Industry Participants Are Leading The Epigenetics Market Growth?#_x000D_

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Epigenetics Market During The Forecast Period?#_x000D_

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Epigenetics Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Epigenetics Market 2025, By The Business Research Company#_x000D_

_x000D_

Viral Vectors And Plasmid Dna Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report_x000D_

_x000D_

Cancer Tumor Profiling Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report_x000D_

_x000D_